Advisor Group Holdings, Inc. Arca Biopharma, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.01 - $2.07 $4 - $4	-2 Reduced 3.51%	55 $0
Q1 2022 May 04, 2022	SELL	$1.77 - $2.49 $88 - $124	-50 Reduced 46.73%	57 $0
Q3 2021 Nov 05, 2021	SELL	$2.77 - $3.74 $138 - $187	-50 Reduced 31.85%	107 $0
Q3 2020 Nov 12, 2020	BUY	$4.07 - $7.99 $407 - $799	100 Added 175.44%	157 $0
Q1 2020 May 18, 2020	BUY	$2.32 - $6.42 $132 - $365	57 New	57 $0

7.23M

54.7K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Market Cap $55.2M
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.